FindTrial
Sign In

to study the effect of nebulized Dexmedetomidine and Dexamethasone in preventing sore throat following endotracheal intubation

Comparative study of nebulized Dexmedetomidine and Dexamethasone in preventing sore throat following endotracheal intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036526
Enrollment
150
Registered
2021-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Preoperative nebulization: Patients will receive nebulized dexamethasone 8ml with 3 ml of normal saline, 15 minutes prior to induction Control Intervention1: Preoperative nebulization:

Sponsors

Dayanand Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I, II and III patients with age group of >=18 years undergoing surgery under general anaesthesia with endotracheal intubation.

Exclusion criteria

Exclusion criteria: 1.History of recent upper respiratory tract infection or sore throat 2.Duration of surgery >3 hrs 3.Mallampati grade >=3 4.Patients who will need more than one intubation attempt •Patient allergic to the drugs used in the study.

Design outcomes

Primary

MeasureTime frame
To compare role of nebulized Dexmedetomidine with Dexamethasone in preventing Post Operative Sore Throat following endotracheal intubation.Timepoint: Immediate postoperatively till 24 hours—

Secondary

MeasureTime frame
To assess any other side effects (if any)Timepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Gurpreeti Grewal

Dayanand Medical College and Hospital Civil Lines Ludhiana 141001 Punjab India

lavinamann30@gmail.com8360133496

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026